<DOC>
	<DOCNO>NCT00298064</DOCNO>
	<brief_summary>The Tissue Repository search case , pull slide , Paraffin-embedded tissue ( PET ) block .</brief_summary>
	<brief_title>Assessment EGFR Genomic Alterations Prognostic Markers Cervical Cancer</brief_title>
	<detailed_description>This study do gather preliminary data determine best way test EGFR expression patient cervical cancer receive treatment EGFR inhibitor future . This study design obtain preliminary data genomic phenotypic alteration EGFR pathway high grade cervical intraepithelial lesion ( HG-SIL ) invasive cervical cancer ( CC ) use later therapeutic guidance evaluate genomic ( over-expression , amplification , point mutation , etc . ) phenotypic alteration transduction pathway interact EGFR pathway .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Samples patient diagnose HGSIL ( n=300 ) CC ( n=300 ) followup least 24 month , exist Department Pathology retrieve Tissue Repository , deidentified provide code number link patient 's data . None Specified .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Cervical cancer</keyword>
	<keyword>EGFR</keyword>
	<keyword>cervical</keyword>
	<keyword>genomic</keyword>
	<keyword>DNA</keyword>
	<keyword>marker</keyword>
	<keyword>prognostic</keyword>
	<keyword>gene</keyword>
	<keyword>epidermal growth factor</keyword>
</DOC>